http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-133945-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d5c5eaca62c75f7617645447443074f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate | 2018-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30acf5fab272b405bbab28ec2aab72fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c5f282815ed29b9dbd8c3786df567e |
| publicationDate | 2020-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RO-133945-A2 |
| titleOfInvention | PROCEDURE FOR THE INSULATION AND PURIFICATION OF VIOLACEIN FOR BIOMEDICAL APPLICATIONS FROM JANTHINOBACTERIUM LIVIDUM CULTURES |
| abstract | The invention relates to a process for isolating and purifying violacin for biomedical applications. The process according to the invention consists in the bacteriophage cultivation a specific solid environment formulated, the sampling of the generated biofilm, the separation of the violacein in volatile organic solvents, the advanced isolation by sorption on inert inorganic substrates, the first purification and then advanced by techniques of chromatographic elution, the bringing into the violet. hydrophilic, the optional formulation of the organic phase containing violacein, using chemical compounds of pharmaceutical purity, admitted by pharmacopoeias and regulatory bodies, depending on the application concerned. |
| priorityDate | 2018-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.